Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Burrows

Showing results (31-40 of 244) with videos related to

Pageof 25
Sort By:
The Australian and New Zealand Journal of Psychiatry|December 1, 1983
Encephalitis, catatonia and schizophreniform illnessF K Judd, G D Burrows
Australian Family Physician|February 1, 1986
Panic and phobic disordersF K Judd, G D Burrows
The Medical Journal of Australia|February 3, 1986
Psychiatry, compensation and rehabilitationF K Judd, G D Burrows
Progress in Brain Research|January 1, 1986
Anxiety and the benzodiazepine receptorT R Norman, G D Burrows
Journal of Clinical Psychopharmacology|April 1, 1997
Mirtazapine: clinical advantages in the treatment of depressionG D Burrows, C M Kremer
The Medical Journal of Australia|January 17, 1994
New medications for the schizophreniasN A Keks, G D Burrows
The Medical Journal of Australia|May 2, 1994
Withdrawal of remoxiprideN A Keks, G D Burrows
The Medical Journal of Australia|October 3, 1994
Suicide, violent behaviour and fluoxetineG D Burrows, T R Horman
Drug Safety|January 1, 1995
A risk-benefit assessment of moclobemide in the treatment of depressive disordersT R Norman, G D Burrows
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1984
Plasma concentrations of benzodiazepines--a review of clinical findings and implicationsT R Norman, G D Burrows
Pageof 25

Showing results (31-40 of 244) with videos related to

Sort By:
Pageof 25
The Australian and New Zealand Journal of Psychiatry|December 1, 1983
Encephalitis, catatonia and schizophreniform illnessF K Judd, G D Burrows
Australian Family Physician|February 1, 1986
Panic and phobic disordersF K Judd, G D Burrows
The Medical Journal of Australia|February 3, 1986
Psychiatry, compensation and rehabilitationF K Judd, G D Burrows
Progress in Brain Research|January 1, 1986
Anxiety and the benzodiazepine receptorT R Norman, G D Burrows
Journal of Clinical Psychopharmacology|April 1, 1997
Mirtazapine: clinical advantages in the treatment of depressionG D Burrows, C M Kremer
The Medical Journal of Australia|January 17, 1994
New medications for the schizophreniasN A Keks, G D Burrows
The Medical Journal of Australia|May 2, 1994
Withdrawal of remoxiprideN A Keks, G D Burrows
The Medical Journal of Australia|October 3, 1994
Suicide, violent behaviour and fluoxetineG D Burrows, T R Horman
Drug Safety|January 1, 1995
A risk-benefit assessment of moclobemide in the treatment of depressive disordersT R Norman, G D Burrows
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1984
Plasma concentrations of benzodiazepines--a review of clinical findings and implicationsT R Norman, G D Burrows
Pageof 25